Microfluidic platforms for modeling biological barriers in the circulatory system

Drug Discov Today. 2018 Apr;23(4):815-829. doi: 10.1016/j.drudis.2018.01.036. Epub 2018 Jan 31.

Abstract

Microfluidic platforms have recently become popular as in vitro models because of their superiority in recapitulating microenvironments compared with conventional in vitro models. By providing various biochemical and biomechanical cues, healthy and diseased models at the organ level can be applied to disease progression and treatment studies. Microfluidic technologies are especially suitable for modeling biological barriers because the flow in the microchannels mimics the blood flow and body fluids at the interfaces of crucial organs, such as lung, intestine, liver, kidney, brain, and skin. These barriers have similar structures and can be studied with similar approaches for the testing of pharmaceutical compounds. Here, we review recent developments in microfluidic platforms for modeling biological barriers in the circulatory system.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Biomimetics / methods
  • Cardiovascular System / physiopathology*
  • Humans
  • Microfluidic Analytical Techniques / methods*
  • Microfluidics / methods*
  • Models, Biological